New injection aims to help shed pounds in major obesity trial
NCT ID NCT06728124
Summary
This large, late-stage study is testing whether a new injection called GZR18 helps adults with obesity or overweight lose weight. About 630 participants in China will receive either the real injection or a placebo (dummy shot) to compare results. The main goal is to see how much weight people lose and to check the treatment's safety over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing
Beijing, China
Conditions
Explore the condition pages connected to this study.